Vaccine biotech Icosavax sets terms for $150 million IPO, Icosavax, a Phase 1 biotech developing vaccines for respiratory diseases, announced terms for its IPO on Thursday.The Seattle, WA-based company plans to raise $150 million by offering 10 million shares at a price range of $14 to $16. At the midpoint of the proposed range, Icosava,

Icosavax, a Phase 1 biotech developing vaccines for respiratory diseases, announced terms for its IPO on Thursday.The Seattle, WA-based company plans to raise $150 million by offering 10 million shares at a price range of $14 to $16. At the midpoint of the proposed range, Icosava

, , Renaissance Capital, {authorlink}, https://www.nasdaq.com/articles/vaccine-biotech-icosavax-sets-terms-for-%24150-million-ipo-2021-07-22, https://www.nasdaq.com/feed/rssoutbound?category=IPOs, IPOs Feed,

This feed is responsible for generating the rss feed related to the topic ipos

, , IPO Calendar, 45, July 22, 2021, 10:06 pm

By A Silva

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.